Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24-28 and 48-52 weeks

CONCLUSION: Among biologics included in these two NMAs, ixekizumab has the highest absolute probability of achieving complete resolution of NP. Results may help to inform treatment decisions for patients with NP.PMID:37781881 | DOI:10.1080/09546634.2023.2263108
Source: Journal of Dermatological Treatment - Category: Dermatology Authors: Source Type: research
More News: Dermatology | Humira | Psoriasis | Skin